Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ARROWHEAD PHARMACEUTICALS, INC.

(ARWR)
  Report
Delayed Nasdaq  -  04:00 2022-12-05 pm EST
31.82 USD   -6.22%
11/30B. Riley Lowers Arrowhead Pharmaceuticals' Price Target to $59 From $65, Keeps Buy Rating
MT
11/29Goldman Sachs Adjusts Price Target on Arrowhead Pharmaceuticals to $66 From $65, Maintains Buy Rating
MT
11/29Jefferies Adjusts Price Target on Arrowhead Pharmaceuticals to $75 From $92, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart ARROWHEAD PHARMACEUTICALS, INC.
Upcoming events on ARROWHEAD PHARMACEUTICALS, INC.
02/09/23 Q1 2023 Earnings Release (Projected)
05/09/23 Interim 2023 Earnings Release (Projected)
08/03/23 Q3 2023 Earnings Release (Projected)
11/27/23 FY 2023 Earnings Release (Projected)
Past events on ARROWHEAD PHARMACEUTICALS, INC.
12/01/22 | 11:20am Evercore ISI HealthCONx Conference
11/30/22 | 02:00pm Piper Sandler Healthcare Conference
11/28/22 | 04:30pm FY 2022 Earnings Call
11/28/22 | 04:00pm FY 2022 Earnings Release
11/09/22 | 10:00am Investor Meeting - Key Opinion Leaders
11/07/22 | 04:08pm American Heart Association Scientific Conference
11/07/22 | 04:00pm American Heart Association Scientific Conference
09/13/22 | 04:20pm Baird Global Healthcare Conference
09/12/22 H.C. Wainwright Global Investment Conference
09/07/22 Wells Fargo Healthcare Conference
Past dividends on ARROWHEAD PHARMACEUTICALS, INC.

- No events available -

Annual results
Fiscal Period : September201820192020202120222023
Sales
M $
Released
Forecast
Spread
16,1
10,4
56%
169
167
1,1%
88,0
135
-35%
138
142
-2,8%
243
294
-17%
 
266
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 
-87,2
-40,4
-116%
-141
-89,9
-57%
-168
-87,9
-91%
 
-236
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-55,9
-57,0
1,9%
61,2
67,0
-8,7%
-93,2
-59,8
-56%
-149
-114
-31%
-179
-135
-33%
 
-201
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-54,4
-55,9
2,6%
61,2
73,0
-16%
-84,6
-42,3
-100%
-141
-108
-30%
-173
-149
-16%
 
-185
 
Net income
M $
Released
Forecast
Spread
-54,5
-55,8
2,4%
68,0
73,0
-6,9%
-84,6
-42,3
-100%
-141
-108
-30%
-176
-149
-18%
 
-150
 
EPS
$
Released
Forecast
Spread
-0,65
-0,67
2,7%
0,69
0,73
-6,0%
-0,84
-0,45
-86%
-1,36
-1,05
-30%
-1,67
-1,46
-14%
 
-1,49
 
Announcement Date12/11/201811/25/201911/23/202011/22/202111/28/2022-
Quarterly results
Fiscal Period : September2021 Q42022 Q12022 Q22022 Q32022 Q42023 Q1
Sales
M $
Released
Forecast
Spread
38,3
42,2
-9,2%
27,4
51,0
-46%
152
131
16%
32,4
52,6
-38%
31,6
91,2
-65%
 
127
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-62,4
-33,4
-87%
-60,7
-85,3
29%
44,1
-20,3
318%
-70,3
-74,5
5,7%
-81,2
-27,2
-198%
 
-14,9
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-64,9
-34,2
-90%
-63,3
-46,0
-38%
41,6
47,4
-12%
-72,9
-67,6
-7,9%
-83,8
-53,8
-56%
 
26,6
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-63,4
-31,0
-105%
-62,9
-32,3
-95%
44,4
17,8
149%
-72,0
-62,7
-15%
-82,2
-58,3
-41%
 
54,2
 
Net income
M $
Released
Forecast
Spread
-63,4
-31,0
-105%
-62,9
-32,3
-95%
44,4
43,9
1,1%
-72,0
-41,1
-75%
-85,5
-58,3
-47%
 
52,9
 
EPS
$
Released
Forecast
Spread
-0,61
-0,30
-105%
-0,60
-0,40
-51%
0,41
0,29
40%
-0,68
-0,47
-44%
-0,81
-0,52
-56%
 
0,35
 
Announcement Date11/22/202102/02/202205/10/202208/04/202211/28/2022-
Previous year Next Year
Upcoming sector events for ARROWHEAD PHARMACEUTICALS, INC.
More events
Past sector events for ARROWHEAD PHARMACEUTICALS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise